Synergistic Vascular Occlusion and Perfusion Control System

The present invention combines the patented low-profile occlusion balloon catheter with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for vascular occlusion and perfusion control, offering enhanced real-time monitoring, optimization, and data management capabilities.

The original patent for the low-profile occlusion balloon catheter addressed the need for vascular pre-conditioning and controlled occlusion during vascular occlusion procedures. However, it had limitations in terms of real-time monitoring and data management. The new inventive concept integrates the patented catheter with emerging technologies to overcome these limitations and provide a more comprehensive solution for vascular occlusion and perfusion control.

The synergistic system comprises the patented low-profile occlusion balloon catheter, an artificial intelligence module for real-time monitoring and optimization of occlusion and perfusion, an IoT-enabled sensor for tracking and monitoring the catheter's position and performance, a blockchain-based data management system for secure and decentralized storage of patient data and treatment outcomes, and a machine learning algorithm to predict and adapt to individual patient responses. The system also incorporates a nanomaterial-based coating for enhanced biocompatibility and reduced thrombogenicity. The AI module analyzes data from the IoT sensor and patient records to optimize occlusion and perfusion in real-time, while the blockchain-based system ensures secure and transparent data management.

The new inventive concept introduces the integration of AI, IoT, blockchain, and new materials with the patented low-profile occlusion balloon catheter, which is not obvious from the original patent. The synergistic combination of these technologies provides a unique solution for vascular occlusion and perfusion control, offering enhanced real-time monitoring, optimization, and data management capabilities.

Alternative embodiments of the inventive concept could include integrating the patented catheter with other emerging technologies such as robotics, computer vision, or advanced materials. Variations could include adapting the system for use in different vascular procedures or developing specialized AI algorithms for specific patient populations.

The synergistic vascular occlusion and perfusion control system has significant commercial potential in the medical device industry, particularly in the fields of cardiology, radiology, and vascular surgery. The system's enhanced real-time monitoring and optimization capabilities, combined with secure and transparent data management, make it an attractive solution for hospitals, clinics, and medical research institutions.